A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li-Fraumeni patients carrying a mutation to the TP53 gene

Oncogene

Volumn 14, Issue 7, 1997, Pages 865-871

  Varley, J M ^a   Thorncroft, M ^a   McGown, G ^a   Appleby, J ^a   Kelsey, A M ^b   Tricker, K J ^b   Evans, Dgr ^a   Birch, J M ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Chromosome 17; Li Fraumeni; LOH; Tumours

Indexed keywords

MICROSATELLITE DNA;

ALLELE; ARTICLE; CANCER GENETICS; CANCER SUSCEPTIBILITY; CHROMOSOME 17; CLINICAL ARTICLE; FAMILIAL CANCER; GENE LOSS; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; PRECANCER; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0031038701     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201041     Document Type: Article

References (66)

1. Birch J. (1990). J. Path., 161, 1-2.
2. Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, Kelsey AM, Harris M, Morris Jones PH, Binchy A, Crowther D, Craft AW, Eden OB, Evans DGR, Thompson E, Mann JR, Martin J, Mitchell ELD and Santibanez-Koref MF. (1994). Cancer Res., 54, 1298-1304.
3. Børresen A-L, Andersen TI, Garber J, Barbier-Piraux N, Thorlacius S, Eyfjörd J, Ottestad L, Smith-Sorensen B, Hovig E, Malkin D and Friend SH. (1992). Cancer Res., 52, 3234-3236.
4. Bowcock AM, Anderson LA, Friedman LS, Black DM, Osborne-Lawrence S, Rowell SE, Hall JM, Solomon E and King M-C. (1993). Am. J. Hum. Genet., 52, 718-722.
5. Brugieres L, Gardes M, Moutou C, Chompret A, Meresse V, Martin A, Poisson N, Flamant F, Bonaiti-Pellie C, Lemerle J and Feunteun J. (1993). Cancer Res., 53, 452-455.
6. Cavenee WK. (1990). Tumor progression stage: Specific losses of heterozygosity. In Genetic basis for carcinogenesis: tumor suppressor genes and oncogenes. Knudson AG, Stanbridge EJ, Sugimura T, Terada M and Watanabe S. (eds) pp. 33-42. Sci. Soc. Press: Japan.
7. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallic BL, Murphree AL, Strong LC and White RL. (1983). Nature, 305, 779-784.
8. Chen P, Iavarone A, Fick J, Edwards M, Prados M and Israel MA. (1995). Cancer Genet. Cytogenet., 82, 106-115.
9. Cho Y, Gorina S, Jeffrey PD and Pavletich NP. (1994). Science, 265, 346-355.
10. Chung R, Whaley J, Kley N, Anderson K, Louis D, Menon A, Hettlich C, Freiman R, Hedley-White ET, Martuza R, Jenkins R, Yandell D and Seizinger BR. (1991). Genes Chromosomes Cancer, 3, 323-331.
11. Coles C, Thompson AM, Elder PA, Cohen BB, Mackenzie IM, Cranston G, Chetty U, Mackay J, Macdonald M, Nakamura Y, Hoyheim B and Steel CM. (1990). Lancet, 336, 761-763.
12. Cornelis RS, Van Vliet M, Vos CBJ, Cleton-Jansen A-M, Van de Vijver MJ, Peterse JL, Kham M, Borresen A-L, Cornelisse CJ and Devilee P. (1994). Cancer Res., 54, 4200-4206.
13. Diller L, Sexsmith E, Gottlieb A, Li FP and Malkin D. (1995). J. Clin. Invest., 95, 1606-1611.
14. Dittmer D, Pati S, Zambetti G, Chu S, Teresky AK, Moore M, Finlay C and Levine AJ. (1993). Nature Genet., 4, 42-46.
15. Eeles RA, Warren W, Knee G, Bartek J, Averill D, Stratton MR, Blake PR, Tait DM, Lane DP, Easton DF, Yarnold JR, Cooper CS and Sloane JP. (1993). Oncogene, 8, 1269-1276.
16. Felix CA, Nau MM, Takahashi T, Mitsudomi T, Chiba I, Poplack DG, Reaman GH, Cole DE, Letterio JJ, Whang-Peng J, Knutsen T and Minna JD. (1992). J. Clin. Invest., 89, 640-647.
17. Felix CA, Slave I, Dunn M, Strauss EA, Phillips PC, Rorke LB, Sutton L, Bunin GR and Biegel JA. (1995). Med. Pediat. Oncol., 25, 431-436.
18. Felix CA, Strauss EA, D'Amico D, Tsokos M, Winter S, Mitsudomi T, Nau MM, Brown DL, Leahey AM, Horowitz ME, Poplack DG, Costin D and Minna JD. (1993). Oncogene, 8, 1203-1210.
19. Frebourg T, Barbier N, Yan Y, Garber JE, Dreyfus M, Fraumeni J, Li FP and Friend SH. (1995). Am. J. Hum. Genet., 56, 608-615.
20. Garber JE, Goldstein AM, Kantor AF, Dreyfus MG, Fraumeni JF and Li FP. (1991). Cancer Res., 51, 6094-6097.
21. Gerken SC, Albertsen H, Elsner T, Ballard L, Holik P, Lawrence E, Moore M, Zhao X and White R. (1995). Am. J. Hum. Genet., 56, 484-499.
22. Grayson GH, Moore S, Schneider BG, Saldivar V and Hensel CH. (1994). Am. J. Pediatr. Hematol. Oncol., 16, 341-347.
23. Gudmundsson J, Johannesdottir G, Bergthorsson JT, Arason A, Ingvarsson S, Egilsson V and Barkardottir R. (1995). Cancer Res., 55, 4830-4832.
24. Gutierrez MI, Bhatia KG, Barreiro C, Spangler G, Schvartzmann E, Muriel FS and Magrath IT. (1994). Hum. Mol. Genet., 3, 2247-2248.
25. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Bernardi G, Lathrop M and Weissenbach J. (1994). Nature Genet., 7, 246-339.
26. Hamelin R, Barichard F, Henry I, Junien C and Thomas G. (1994). Hum. Genet., 94, 88-90.
27. Heim S and Mitelman F. (1995). Cancer Cytogenetics. Second Edition. Wiley-Liss.
28. Hoggard N, Brintnell B, Howell A, Weissenbach J and Varley J. (1995). Genes Chromosomes Cancer, 12, 24-31.
29. Hollstein M, Shomer B, Greenblatt M, Soussi T, Hovig E, Montesano R and Harris CC. (1996). Nucleic Acids Res., 24, 141-146.
30. Hollstein M, Sidransky D, Vogelstein B and Harris CC. (1991). Science, 253, 49-53.
31. Horio Y, Suzuki H, Ueda R, Koshikawa T, Sugiura T, Ariyoshi Y, Shimokata K, Takahashi T and Takahashi T. (1994). Oncogene, 9, 1231-1235.
32. Iavarone A, Matthay KK, Steinkirchner TM and Israel MA. (1992). Proc. Natl. Acad. Sci. USA, 89, 4207-4209.
33. Ichii S, Horii A, Nakatsuru S, Furuyama J, Utsunomiya J and Nakamura Y. (1992). Hum. Mol. Genet., 1, 387-390.
34. Jolly KW, Malkin D, Douglass EC, Brown TF, Sinclair AE and Look AT. (1994). Oncogene, 9, 97-102.
35. Knudson AG Jr. (1971). Proc. Natl. Acad. Sci. USA, 68, 820-823.
36. Kovar H, Auinger A, Jug G, Müller T and Pillwein K. (1992). Oncogene, 7, 2169-2173.
37. Kyritsis AP, Bondy ML, Xiao M, Berman EL, Cunningham JE, Lee PS, Levin VA and Saya H. (1994). JNCI, 86, 344-349.
38. Lane DP. (1992). Nature, 358, 15-16.
39. Levine AJ, Momand J and Finlay CA. (1991). Nature, 351, 453-456.
40. Li FP and Fraumeni JF. (1969). Ann. Intern. Med., 71, 747-752.
41. Li FP, Fraumeni JF, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA and Miller RW. (1988). Cancer Res., 48, 5358-5362.
42. Li Y-J, Sanson M, Hoang-Xuan K, Delattre J-Y, Poisson M, Thomas G and Hamelin R. (1995). Int. J. Cancer, 64, 383-387.
43. Lubbe J, von Ammon K, Watanabe K, Hegi ME and Kleihues P. (1995). Brain Path., 5, 15-23.
44. Mackay J, Steel CM, Elder PA, Forrest APM and Evans HJ. (1988). Lancet, ii, 1384-1385.
45. Malkin D, Jolly KW, Barbier N, Look AT, Friend SH, Gebhardt MC, Andersen TI, Børresen A-L, Li FP, Garber J and Strong L. (1992). New Engl. J. Med., 326, 1309-1315.
46. Malkin D, Li FP, Strong LC, Fraumeni JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA and Friend SH. (1990). Science, 250, 1233-1238.
47. McIntyre JF, Smith-Sorensen B, Friend SH, Kassell J, Borresen A-L, Van YX, Russo C, Sato J, Barbier N, Miser J, Malkin D and Gebhardt MC. (1994). J. Clin. Oncol, 12, 925-930.
48. Metzger AK, Sheffield VC, Duyk G, Daneshvar L, Edwards MSB and Cogen PH. (1991). Proc. Natl. Acad. Sci. USA, 88, 7825-7829.
49. Mukhopadhyay T and Roth JA. (1993). Cancer Res., 53, 4362-4366.
50. Ory K, Legros Y, Auguin C and Soussi T. (1994). EMBO J., 13, 3496-3504.
51. Plummer SJ, Santibanez-Koref M, Kurosaki T, Liao S, Noble B, Fain PR, Anton-Culver H and Casey G. (1994). Oncogene, 9, 3273-3280.
52. Ponder BA. (1988). Nature, 335, 400-402.
53. Prosser J, Porter D, Coles C, Condie A, Thompson AM, Chetty U, Steel CM and Evans HJ. (1992). Br. J. Cancer, 65, 527-528.
54. Sameshima Y, Tsunematsu Y, Watanabe S, Tsukamoto T, Kawa-ha K, Hirata Y, Mizoguchi H, Sugimura T, Terada M and Yokota J. (1992). JNCI, 84, 703-707.
55. Scott RJ, Krummenacher F, Mary J-L, Weber W, Spycher M and Muller H. (1993). Schweiz Med Wochenschr, 123, 1287-1292.
56. Smith SA, Easton DF, Evans DGR and Ponder BAJ. (1992). Nature Genet., 2, 128-131.
57. Srivastava S, Tong YA, Devadas K, Zou Z-Q, Sykes VW, Chen Y, Blattner WA, Pirollo K and Chang EH. (1992). Oncogene, 7, 987-991.
58. Stack M, Jones D, White G, Liscia DS, Venesio T, Casey G, Crichton D, Varley J, Mitchell E, Heighway J and Santibanez-Koref M. (1995). Hum. Mol. Genet., 4, 2047-2055.
59. Toguchida J, Yamaguchi T, Dayton SH, Beauchamp RL, Herrera GE, Ishizaki K, Yamamuro T, Meyers PA, Little JB, Sasaki MS, Weichselbaum RR and Yandell DW. (1992). New Engl. J. Med., 326, 1301-1308.
60. Tory K, Brauch H, Linehan M, Barba D, Oldfield E, Filling-Katz M, Seizinger B, Nakamura Y, White R, Marshall FF, Lerman MI and Zbar B. (1989). JNCI, 81, 1097-1101.
61. Varley JM, McGown G, Thorncroft M, Cochrane S, Morrison P, Woll P, Kelsey AM, Mitchell ELD, Boyle J, Birch JM and Evans DGR. (1996). Oncogene, 12, 2437-2442.
62. Varley JM, McGown G, Thorncroft M, Santibanez-Koref MF, Kelsey AM, Tricker KM, Evans DGR and Birch JM. (1997). Manuscript submitted.
63. Wagner J, Portwine C, Rabin K, Leclerc J-M, Narod SA and Malkin D. (1994). JNCI, 86, 1707-1710.
64. Warneford SG, Witton LJ, Townsend ML, Rowe PB, Reddel RR, Dalla-Pozza L and Symonds G. (1992). Cell Growth Differ., 3, 839-846.
65. Williams KJ, Boyle JM, Birch JM, Norton JD and Scott D. (1996). Oncogene, in press.
66. Zhu X, Dunn JM, Goddard AD, Squire JA, Becker A, Phillips RA and Gallie BL. (1992). Cytogenet. Cell Genet., 59, 248-252.